Guggenheim Remains a Hold on Exelixis (EXEL)

In a report released yesterday, from Guggenheim maintained a Hold rating on Exelixis. The company’s shares closed yesterday at $48.70.

Claim 55% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Exelixis with a $48.00 average price target, which is a -1.44% downside from current levels. In a report released yesterday, Barclays also maintained a Hold rating on the stock with a $45.00 price target.

Based on Exelixis’ latest earnings release for the quarter ending January 2, the company reported a quarterly revenue of $598.66 million and a net profit of $244.53 million. In comparison, last year the company earned a revenue of $566.76 million and had a net profit of $139.86 million

Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EXEL in relation to earlier this year. Most recently, in February 2026, Aftab Dana, the EVP, Research and Development of EXEL sold 47,918.00 shares for a total of $2,132,351.00.